LSCIBC LifeSci Biotechnology Clinical Trials Index

The Index is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development.

0.00
As of 06/26/2022


Index Information
Provider:     LifeSci Index Partners
Category1:  US Equity
Category2:  Single industry
Category3:  Biotechnology
Country:      USA
Currency:    USD
Inception date:  11/03/2014
Backtesting data exists:   Yes
Weighting methodology:   Equal weighted
Number of holdings:  94  (as of 02/28/2019)

As explained in what is an index, there is no universal system of giving an index a symbol. You can search for indexes using our index symbol lookup.

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy